SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-046700
Filing Date
2017-02-16
Accepted
2017-02-16 16:13:03
Documents
5
Period of Report
2017-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d540691d8k.htm 8-K 34588
2 EX-3.1 d540691dex31.htm EX-3.1 12154
3 EX-3.2 d540691dex32.htm EX-3.2 46557
4 EX-4.1 d540691dex41.htm EX-4.1 15321
5 EX-99.1 d540691dex991.htm EX-99.1 11138
  Complete submission text file 0001193125-17-046700.txt   121462
Mailing Address 125 BINNEY STREET CAMBRIDGE MA 02142
Business Address 125 BINNEY STREET CAMBRIDGE MA 02142 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36172 | Film No.: 17618086
SIC: 2836 Biological Products, (No Diagnostic Substances)